Further work is required to assess the ability of BAG-1 to predict response to adjuvant therapy, in particular given the role of BAG-1 in modulation of NHR function, and the importance of adjuvant hormonal therapy in breast cancer. Here, BAG1 is linked to breast carcinoma.